Assignee
JANSSEN VACCINES & PREVENTION BV
NL·96 granted patents·36 pending applications·172 citations·filing 2014–2023
Top patents by PatentIndex Score
132 records- 0195US11229694B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jan 25, 2022·9 cites·8 claims
- 0294US11338031B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted May 24, 2022·5 cites·18 claims
- 0394US10456462B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Oct 29, 2019·8 cites·6 claims
- 0493US10899800B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2014·Granted Jan 26, 2021·12 cites·38 claims
- 0593US10729757B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Aug 4, 2020·15 cites·31 claims
- 0692US9790256B2Therapeutic HPV18 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Oct 17, 2017·14 cites·28 claims
- 0791US11229695B2Method for the safe induction of immunity against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·8 cites·11 claims
- 0891US11155583B2Stabilized soluble pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Oct 26, 2021·7 cites·19 claims
- 0991US10953087B2Stabilized pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Mar 23, 2021·5 cites·32 claims
- 1090US11229692B2Methods and compositions for inducing protective immunity against RSV infectionJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·8 cites·14 claims
- 1188US11365222B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted Jun 21, 2022·2 cites·21 claims
- 1288US11034731B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jun 15, 2021·5 cites·16 claims
- 1387US10968254B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Apr 6, 2021·3 cites·22 claims
- 1487US10744196B2HPV vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Aug 18, 2020·4 cites·25 claims
- 1587US10370435B2Binding molecules directed against influenza hemagglutinin and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·6 cites·9 claims
- 1687US10301379B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2015·Granted May 28, 2019·7 cites·23 claims
- 1787US10071151B2Therapeutic HPV16 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Sep 11, 2018·5 cites·21 claims
- 1886US11723970B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 1985US10525123B2Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatmentJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jan 7, 2020·3 cites·20 claims
- 2085US10457708B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Oct 29, 2019·3 cites·14 claims
- 2185US10369214B2Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·5 cites·51 claims
- 2284US10307477B2Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatmentJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Jun 4, 2019·3 cites·20 claims
- 2383US11472869B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Oct 18, 2022·1 cites·18 claims
- 2483US10793607B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Oct 6, 2020·2 cites·23 claims
- 2582US9969778B2Influenza virus vaccines and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted May 15, 2018·4 cites·4 claims
- 2681US11207400B2Compositions and methods for inducing protective immunity against human immunodeficiency virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Dec 28, 2021·1 cites·20 claims
- 2781US10703804B2Binding molecules directed against influenza hemagglutinin and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jul 7, 2020·1 cites·22 claims
- 2881US10562963B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Feb 18, 2020·1 cites·3 claims
- 2981US10555996B2Therapeutic HPV16 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Feb 11, 2020·2 cites·28 claims
- 3081US10294279B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2014·Granted May 21, 2019·5 cites·22 claims
- 3178US11235051B2Methods and compositions for heterologous repRNA immunizationsJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Feb 1, 2022·1 cites·21 claims
- 3278US11229693B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·1 cites·20 claims
- 3378US10703803B2Human neutralizing antibodies binding to influenza B neuraminidaseJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Jul 7, 2020·3 cites·26 claims
- 3476US11801297B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Oct 31, 2023·0 cites·1 claims
- 3576US10174127B2Human neutralizing antibodies binding to influenza neuraminidaseJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Jan 8, 2019·3 cites·22 claims
- 3675US11998597B2Vaccine against RSVJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Jun 4, 2024·0 cites·20 claims
- 3775US11820796B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2022·Granted Nov 21, 2023·0 cites·15 claims
- 3875US2023374078A1Trimer Stabilizing HIV Envelope Protein MutationsJANSSEN VACCINES & PREVENTION BV·Filed 2023·Application pending·0 cites
- 3974US10471137B2Methods for inducing protective immunity against human immunodeficiency virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Nov 12, 2019·1 cites·27 claims
- 4073US2023265127A1Stabilized soluble pre-fusion rsv f polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 4173US2022096622A1Compositions and Methods for Inducing Protective Immunity Against Human Immunodeficiency Virus InfectionJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 4272US10844096B2Therapeutic HPV18 vaccinesJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Nov 24, 2020·0 cites·26 claims
- 4372US10117925B2Influenza virus vaccines and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2015·Granted Nov 6, 2018·2 cites·21 claims
- 4471US12234264B2Stabilized soluble pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 25, 2025·0 cites·8 claims
- 4571US11896663B2Immunodeficiency virus type 1 (HIV-1) mutant envelope proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 13, 2024·0 cites·6 claims
- 4671US11484494B2Adenovirus formulationsJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Nov 1, 2022·0 cites·20 claims
- 4771US10738083B2Influenza virus neutralizing peptidomimetic compoundsJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 11, 2020·1 cites·32 claims
- 4871US10400034B2Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tauJANSSEN VACCINES & PREVENTION BV·Filed 2015·Granted Sep 3, 2019·1 cites·11 claims
- 4970US11732010B2Trimer stabilizing HIV envelope protein mutationsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
- 5070US11136379B2Binding molecules directed against influenza hemagglutinin and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted Oct 5, 2021·0 cites·17 claims
Showing the top 50 of 132 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when JANSSEN VACCINES & PREVENTION BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →